The Indian pharmaceutical contract manufacturing market is anticipated to grow at a favourable CAGR of around 13.3% during the forecast period(2022-2028). The prominent factor that boosts the growth of the Indian pharmaceutical contract manufacturing market, are the growing aging population, emerging medical conditions, and the emergence of new diseases. The Indian pharma industry has achieved significant growth in both domestic and global markets during the forecast period. The pharma industry in India contributes more than 20% by volume of the global generics market and 62% of the global demand for vaccines. The Indian domestic pharmaceutical market size has reached $20.3 billion in 2019 with a growth of 9.8%, according to the University of New Mexico.
Browse the full report description of “Indian Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Category (Human Based Drugs, and Animals Based Drugs) by Type ( Sterile Manufacturing, Non-Sterile Manufacturing) by Product (Over-The-Counter (Otc) Drugs, Active Pharmaceutical Ingredients (Api), Finished Dosage Formulation (Solid Dose, Liquid Dose and Injectable Dose), Others (Nutritional Products and Packaging) by Services(Manufacturing Services, Non-Clinical Services Such as Supply Chain Management, and Research and Development) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/indian-pharmaceutical-contract-manufacturing-market
The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2020, Roche Pharma expanded its partnership with Cipla to further improve access to the key oncology medicines in India. With this partnership, Roche Pharma expands the scope of marketing and distribution of oncology drugs trastuzumab, bevacizumab, and rituximab in India.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2021-2028
• Segment Covered- by category, by type, by product, by services
• Competitive Landscape- Dishman Group, Dr Reddy’s Laboratories Ltd., Gracure Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Piramal Group, Divis Laboratories Ltd., Dupen Laboratories, Finecure Pharmaceuticals Ltd., Green Cross Remedies, and others.
• Key questions addressed by the report
• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Indian Pharmaceutical Contract Manufacturing Market– Segmentation
By Category
By Type
By Product
By Services
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/indian-pharmaceutical-contract-manufacturing-market